Journal of Clinical Medicine (May 2021)

Amyloid Goiter in Familial Mediterranean Fever: Description of 42 Cases from a French Cohort and from Literature Review

  • Hélène Vergneault,
  • Alexandre Terré,
  • David Buob,
  • Camille Buffet,
  • Anael Dumont,
  • Samuel Ardois,
  • Léa Savey,
  • Agathe Pardon,
  • Pierre-Antoine Michel,
  • Jean-Jacques Boffa,
  • Gilles Grateau,
  • Sophie Georgin-Lavialle

DOI
https://doi.org/10.3390/jcm10091983
Journal volume & issue
Vol. 10, no. 9
p. 1983

Abstract

Read online

Our aim was to describe the main features of amyloid goiter in adults with amyloidosis secondary to familial Mediterranean fever. Therefore, we analyzed cases from a French cohort of familial Mediterranean fever patients with amyloidosis and from literature review. Forty-two cases were identified: 9 from the French cohort and 33 from literature review. Ninety percent of patients were on hemodialysis for renal amyloidosis before the development of goiter. The goiter grew up rapidly in 88% of cases; 75.6% of patients were euthyroid, 58% displayed dyspnea, and 44.8% dysphagia. Various features were seen on ultrasound, from diffuse to multinodular goiter. When it was performed, fine-needle aspiration biopsy almost always revealed amyloidosis. Thirty-one patients underwent thyroidectomy: to manage compressive symptoms (72%) or rule out malignancy (27%). Histology showed mature adipose tissue in 64% of cases and lymphocytic infiltration in 21.4%. In conclusion, amyloid goiter in familial Mediterranean fever preferentially occurs in patients with end stage renal failure. Fine-needle aspiration biopsy seems to be a sensitive exam for diagnosis, but thyroidectomy remains sometimes necessary to rule out malignancy or release compressive symptoms.

Keywords